In the last 15 years, the landscape of diabetes and obesity management has been significantly transformed by the advent of GLP-1 receptor agonists which are about to become the most successful drugs in the history of medicine, eclipsing drugs like insulin and statin. Dr Alain Bouchard, MD discusses with Dr. Timothy Garvey, Professor of Medicine in the Department of Nutrition Sciences at the University of Alabama at Birmingham.